Day Trading Reports
  • Business
  • World News
  • Politics
  • Investing
  • Business
  • World News
  • Politics
  • Investing

Day Trading Reports

Politics

Pro-life movement confronts high abortion rates three years after Dobbs

by admin June 23, 2025
June 23, 2025
Pro-life movement confronts high abortion rates three years after Dobbs

A 50-year fight to put abortion back in the hands of states ended three years ago with the Supreme Court’s landmark Dobbs decision, but the pro-life movement is now grappling with a new reality — abortion remains prevalent.

Since securing the legal victory, abortion opponents’ concentration has become more fragmented as they contend with evidence that abortions have not decreased and could even be on the rise.

Their next big challenges, they say, include neutering the nation’s largest abortion vendor, Planned Parenthood, by targeting its funding. Restricting access to pills that terminate pregnancies is another top priority, as is investing in their preferred political candidates and ballot measures. 

Marjorie Dannenfelser, president of SBA Pro-Life America, told Fox News Digital in an interview that Dobbs prompted a ‘revolution,’ but she acknowledged that ‘there is a lot of work to do.’ She noted the Charlotte Lozier Institute found that abortions increased in the year after Dobbs and that at least 1.1 million occurred from July 2023 to June 2024.

‘People can sort of assume or just forget how big a moment [Dobbs] is. . . . It is shaking up and realigning public opinion based on where they really stand, so building consensus,’ Dannenfelser said. ‘It would be false to think that it could happen overnight, and we’re still right in the middle of it.’

She said she feels the prospect of defunding Planned Parenthood through a broader reconciliation bill in Congress is ‘strong.’ The measure would prohibit Medicaid funds for entities that perform abortions outside of rape, incest, and a threat to a mother’s life.

Planned Parenthood said in a statement in May, after the bill passed the Republican-led House, that the provision would eliminate other services besides abortion and could cause about 200 of its roughly 600 locations to shutter.

‘If this bill passes, people will lose access to essential, often lifesaving care — cancer screenings, birth control, STI testing, and yes, abortion,’ the organization said in a statement at the time.

In 2021, the Food and Drug Administration (FDA) eliminated a requirement that a customer must appear in person to receive mifepristone, the pill used to end a pregnancy. The pills became available by mail, and they are now being shipped all over the country from various organizations, including to most of the states that have abortion bans in place.

‘The abortion drugs that are being proliferated by big abortion and Planned Parenthood is a direct assault on the sovereignty of states,’ Dannenfelser said, noting that ‘the people of half the states have said this is the pro-life law that we want, so in order to undermine that and press their agenda, the abortion lobby is promoting abortion tourism across state lines.’

Dannenfelser also said her group, which, alongside its campaign fundraising arm, poured $92 million into the 2024 election cycle, is focused on next year’s midterm races. She noted she wants to maintain a ‘trifecta of pro-life administration, House and Senate.’ 

But some of those hoping to eliminate abortion say the current administration could do more to help their bottom line.

President Donald Trump granted clemency when he took office to nearly two dozen activists who were convicted of blocking abortion clinic entrances, and the president often touts that he appointed three justices who voted to overturn Roe v. Wade.

But in terms of the abortion pill, the Trump administration recently moved to dismiss a case in court aiming to tighten FDA restrictions on mifepristone. Trump has vowed to have Health and Human Services Secretary Robert F. Kennedy, Jr., who is openly supportive of abortion access, conduct a study of the pill.

Katie Xavios, the national director of the American Life League, told Fox News Digital that she believes Trump ‘really hasn’t been the staunchest pro-life advocate.’

She said mifepristone distribution has ‘no guardrails.’ Dozens of organizations now offer easy access to the pill. Xavios said abortions-by-mail have become the ‘wild west,’ and that the government would have to work aggressively to contain it at this point.

‘I don’t think we’ll ever see anybody take that away unless we can really get a very truly pro-life person in office,’ Xavios said.

American Life League is a Catholic grassroots organization, and Xavios said one of her group’s efforts is to instill values in children that would lead them to opt against abortion if they were faced with the decision in adulthood.

Dobbs was not the win for her side that people have framed it to be, she said.

‘I think we’re still kind of seeing the reverberations of that a little bit in the movement, where a lot of people are struggling to find a new legal fight,’ Xavios said. ‘But I think the real issue that we’re left with is it doesn’t matter if it’s legal or not if people don’t really respect and value the dignity of the pre-born.’

This post appeared first on FOX NEWS

previous post
Russian leader claims multiple countries prepped to provide Iran nuclear weapons following US strikes
next post
Recovered Bayesian superyacht transferred to Sicilian port after being raised from seabed

Related Posts

GOP unveils new weapon to help slash billions...

June 11, 2025

US troops in the Middle East could face...

June 20, 2025

These are the ‘Dirty 15’ countries Trump might...

April 3, 2025

World Press Freedom Day: Release my father Jimmy...

May 4, 2025

First lady Melania Trump’s new official portrait revealed

January 28, 2025

Trump launches precision strikes against Iran. Triumph or...

June 22, 2025

Hakeem Jeffries blames Trump for Newark Airport chaos,...

May 6, 2025

Donald Trump and Elon Musk are an unusual...

April 7, 2025

Trump feels in ‘good shape,’ after physical, says...

April 12, 2025

Senate advances Trump’s pick to lead the US...

January 30, 2025

    Become a VIP member by signing up for our newsletter. Enjoy exclusive content, early access to sales, and special offers just for you! As a VIP, you'll receive personalized updates, loyalty rewards, and invitations to private events. Elevate your experience and join our exclusive community today!


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Editors’ Picks

    • 1

      Forum Energy Metals and Global Uranium Announce Exploration Update on Drill Targeting, Northwest Athabasca Project, Saskatchewan

      January 31, 2025
    • 2

      Mega M&A: Rio Tinto-Glencore Merger Sparks Chatter

      January 28, 2025
    • 3

      Excellent 90% recoveries at Cork Tree Well & Board Update

      February 17, 2025
    • 4

      Financial Agreement signed releasing $2M grant

      January 23, 2025
    • 5

      Netflix shares soar as company reports surging revenue, tops 300 million subscribers

      January 23, 2025
    • 6

      Cyclopharm Signs US Agreement with HCA Healthcare for Technegas®

      January 23, 2025
    • 7

      FDA officially authorizes Zyn nicotine pouches for sale following health review

      January 23, 2025
    • About us
    • Contacts
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: daytradingreports.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.


    Copyright © 2025 daytradingreports.com | All Rights Reserved